Cara Therapeutics

2 followers


Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.

Industries

Headquarters

Stage

Employees

Links

Org chart

Christopher Posner
CEO, President & Director

Christopher Posner

Collapse
Iris Francesconi
Chief Strategy Officer & Head of Investor Relations
Frédérique Menzaghi
Chief Scientific Officer, SVP Research & Development
Jo Goncalves
Chief Medical Officer
Scott Terrillion
General Counsel, Secretary & Chief Compliance Officer
Eric Vandal
SVP, Commercial
Beth Weinberg
SVP, Regulatory Affairs & QA